NOX 0.00% 7.2¢ noxopharm limited

Extract from European Patent Office communication yesterday: For...

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    Extract from European Patent Office communication yesterday:

    For the intended grant of the European patent, the bibliographic data are set out below, for information:

    Title of Invention:  ISOFLAVONOID COMPOSITION WITH IMPROVED PHARMACOKINETICS

    Details of the application were updated by Noxopharm on 14 May, as requested by the EPO, as a prelude to the formal grant of patent protection.

    Patent grant will take place when all formalities are complete.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.